In addition, we found changes in the expression of immune checkpoints, including PD-1 and TIGIT on cd47−/− CD8 cells in the tumor microenvironment that could impair their function and suggest crosstalk between CD47 signaling and other immune checkpoint pathways [23]. The gene discussed is CD47; the disease is neoplasm.